🚨 $SPRB
On November 9, 2026, Spruce Biosciences, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026 and providing corporate updates.
On November 9, 2026, Spruce Biosciences, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026 and providing corporate updates.
SEC Filing: SPRB
Click to view the official SEC document.
www.sec.gov
November 9, 2026 at 1:05 PM
🚨 $SPRB
On November 9, 2026, Spruce Biosciences, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026 and providing corporate updates.
On November 9, 2026, Spruce Biosciences, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026 and providing corporate updates.
#SPRB Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
https://www.stocktitan.net/news/SPRB/spruce-biosciences-reports-third-quarter-2026-financial-results-and-tuozl36zfaaz.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-reports-third-quarter-2026-financial-results-and-tuozl36zfaaz.html?utm_source=stocktitan-bluesky&utm_medium=social
Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 9, 2026 at 1:00 PM
#SPRB Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
https://www.stocktitan.net/news/SPRB/spruce-biosciences-reports-third-quarter-2026-financial-results-and-tuozl36zfaaz.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-reports-third-quarter-2026-financial-results-and-tuozl36zfaaz.html?utm_source=stocktitan-bluesky&utm_medium=social
#SPRB Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-separation-of-crhx-101-formerly-spr-202-5vu0c0ve4ip3.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-separation-of-crhx-101-formerly-spr-202-5vu0c0ve4ip3.html?utm_source=stocktitan-bluesky&utm_medium=social
Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 9, 2026 at 12:00 PM
#SPRB Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-separation-of-crhx-101-formerly-spr-202-5vu0c0ve4ip3.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-separation-of-crhx-101-formerly-spr-202-5vu0c0ve4ip3.html?utm_source=stocktitan-bluesky&utm_medium=social
#SPRB Spruce Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-guggenheim-3rd-annual-ad65k1mpayp6.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-guggenheim-3rd-annual-ad65k1mpayp6.html?utm_source=stocktitan-bluesky&utm_medium=social
www.stocktitan.net
November 2, 2026 at 9:05 PM
#SPRB Spruce Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-guggenheim-3rd-annual-ad65k1mpayp6.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-guggenheim-3rd-annual-ad65k1mpayp6.html?utm_source=stocktitan-bluesky&utm_medium=social
#SPRB Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-craig-hallum-biotech-4vyb5g2srkn2.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-craig-hallum-biotech-4vyb5g2srkn2.html?utm_source=stocktitan-bluesky&utm_medium=social
Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 15, 2026 at 8:05 PM
#SPRB Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-craig-hallum-biotech-4vyb5g2srkn2.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-to-participate-in-the-craig-hallum-biotech-4vyb5g2srkn2.html?utm_source=stocktitan-bluesky&utm_medium=social
#SPRB Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-presentation-of-mps-iiib-natural-164hwoifshtl.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-presentation-of-mps-iiib-natural-164hwoifshtl.html?utm_source=stocktitan-bluesky&utm_medium=social
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 8, 2026 at 8:05 PM
#SPRB Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-presentation-of-mps-iiib-natural-164hwoifshtl.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-presentation-of-mps-iiib-natural-164hwoifshtl.html?utm_source=stocktitan-bluesky&utm_medium=social
#SPRB Spruce Biosciences Announces Launch of MPS3BStudy.com
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-launch-of-mps3b-study-9mussscbufnv.html
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-launch-of-mps3b-study-9mussscbufnv.html
Children With MPS IIIB Have No FDA-Approved Therapies; Spruce Plans Studies
Families can review eligibility for programs expected to start as early as Q4 2026, with about 10 EAP participants and 14 in the confirmatory study.
www.stocktitan.net
August 26, 2026 at 12:00 PM
#SPRB Spruce Biosciences Announces Launch of MPS3BStudy.com
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-launch-of-mps3b-study-9mussscbufnv.html
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-launch-of-mps3b-study-9mussscbufnv.html
📈 SPRB (Spruce Biosciences) +13.7% since we peeled back the filing
Filed: Aug 24, 2026 | 08:00 ET | Now: Aug 24, 2026 | 17:00 ET
At filing: $51.58 to Now: $58.65
Score: 8/10 | Positive
Headlines are late. Filings aren't.
Read the original breakdown (sourced from Wiseek):
Filed: Aug 24, 2026 | 08:00 ET | Now: Aug 24, 2026 | 17:00 ET
At filing: $51.58 to Now: $58.65
Score: 8/10 | Positive
Headlines are late. Filings aren't.
Read the original breakdown (sourced from Wiseek):
August 24, 2026 at 9:01 PM
📈 SPRB (Spruce Biosciences) +13.7% since we peeled back the filing
Filed: Aug 24, 2026 | 08:00 ET | Now: Aug 24, 2026 | 17:00 ET
At filing: $51.58 to Now: $58.65
Score: 8/10 | Positive
Headlines are late. Filings aren't.
Read the original breakdown (sourced from Wiseek):
Filed: Aug 24, 2026 | 08:00 ET | Now: Aug 24, 2026 | 17:00 ET
At filing: $51.58 to Now: $58.65
Score: 8/10 | Positive
Headlines are late. Filings aren't.
Read the original breakdown (sourced from Wiseek):
BUY $SPRB (SPRB.O) [FDA] @ 12:00:00Z
August 24, 2026 at 12:00 PM
BUY $SPRB (SPRB.O) [FDA] @ 12:00:00Z
#SPRB Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-positive-pre-bla-meetings-with-fda-and-n84jewyc07wu.html
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-positive-pre-bla-meetings-with-fda-and-n84jewyc07wu.html
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Spruce Biosciences (Nasdaq: SPRB) reported successful completion of two pre-BLA meetings with the FDA supporting its plan to submit a biologics license application (BLA) in the fourth quarter of 2026 for tralesinidase alfa enzyme replacement therapy (TA-ERT) to treat Sanfilippo Syndrome Type B (MPS IIIB).The FDA found Spruce’s chemistry, manufacturing and controls (CMC) analytical comparability strategies reasonable after technology transfer to a leading global biologics manufacturer and aligned with the overall content and format of the planned BLA, including integrated efficacy and safety summaries. Spruce has completed commercial-scale technology transfer, manufactured registrational drug product batches, and produced the first process performance qualification (PPQ) batch, with the second PPQ batch expected in Q4 2026. The FDA has maintained support for an accelerated approval pathway based on reduction of cerebrospinal fluid heparan sulfate non-reducing ends (CSF HS-NRE), with a confirmatory study allowed to start during BLA review. TA-ERT holds multiple U.S. expedited and orphan designations and may qualify for a rare pediatric disease priority review voucher if approved.
www.stocktitan.net
August 24, 2026 at 12:00 PM
#SPRB Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-positive-pre-bla-meetings-with-fda-and-n84jewyc07wu.html
https://www.stocktitan.net/news/SPRB/spruce-biosciences-announces-positive-pre-bla-meetings-with-fda-and-n84jewyc07wu.html
Threads
www.threads.com
August 24, 2026 at 2:38 AM
🧬 Biotech is back.
$SPRB’s +1900% run and $NVO’s AI drug deals reignited the sector.
$XBI up ~9% this month, ~16% YTD, momentum’s real, volatility too.
Watch: $NVO | $SPRB | $XBI
Biotech breakout or just hype?
$SPRB’s +1900% run and $NVO’s AI drug deals reignited the sector.
$XBI up ~9% this month, ~16% YTD, momentum’s real, volatility too.
Watch: $NVO | $SPRB | $XBI
Biotech breakout or just hype?
October 20, 2025 at 1:33 AM
🧬 Biotech is back.
$SPRB’s +1900% run and $NVO’s AI drug deals reignited the sector.
$XBI up ~9% this month, ~16% YTD, momentum’s real, volatility too.
Watch: $NVO | $SPRB | $XBI
Biotech breakout or just hype?
$SPRB’s +1900% run and $NVO’s AI drug deals reignited the sector.
$XBI up ~9% this month, ~16% YTD, momentum’s real, volatility too.
Watch: $NVO | $SPRB | $XBI
Biotech breakout or just hype?
Spruce Biosciences raises $69M in public offering, selling 1.38M shares at $50 each
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-167332/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-167332/
June 3, 2026 at 1:10 AM
Spruce Biosciences raises $69M in public offering, selling 1.38M shares at $50 each
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-167332/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-167332/
Spruce raises $84M, resolves going concern, targets Q4 2026 BLA for lead rare disease therapy
$SPRB 10-Q → https://filingdiff.com/ticker/SPRB/0001193125-26-221605/
$SPRB 10-Q → https://filingdiff.com/ticker/SPRB/0001193125-26-221605/
June 1, 2026 at 5:40 PM
Spruce raises $84M, resolves going concern, targets Q4 2026 BLA for lead rare disease therapy
$SPRB 10-Q → https://filingdiff.com/ticker/SPRB/0001193125-26-221605/
$SPRB 10-Q → https://filingdiff.com/ticker/SPRB/0001193125-26-221605/
Spruce Biosciences reports $107.3M cash position and Q1 2026 results
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-220648/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-220648/
June 1, 2026 at 5:40 PM
Spruce Biosciences reports $107.3M cash position and Q1 2026 results
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-220648/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-220648/
Spruce Biosciences holds routine 2026 Annual Meeting, re-elects directors through 2029
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-239230/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-239230/
May 27, 2026 at 11:40 PM
Spruce Biosciences holds routine 2026 Annual Meeting, re-elects directors through 2029
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-239230/
$SPRB 8-K → https://filingdiff.com/ticker/SPRB/0001193125-26-239230/
Did you ever read Alexandra Erin's parody of the style, as "John Z. Upjohn" ?
www.alexandraerin.com/2015/05/sprb...
www.alexandraerin.com/2015/05/sprb...
Sad Puppies Review Books: RICHARD SCARRY’S BEST WORD BOOK EVER
Richard Scarry’s Best Word Book Ever Reviewed by John Z. Upjohn, USMC (Aspired) With gratitude to my brother in Christ, Mr. John C. Wright, for his gift of words. Dear Mr. Scarry, I ad…
www.alexandraerin.com
October 3, 2025 at 2:54 PM
Did you ever read Alexandra Erin's parody of the style, as "John Z. Upjohn" ?
www.alexandraerin.com/2015/05/sprb...
www.alexandraerin.com/2015/05/sprb...
SLRB et SPRB : nominations au parfum politique par le gouvernement bruxellois en affaires courantes
SLRB et SPRB : nominations au parfum politique par le gouvernement bruxellois en affaires courantes - L-Post
Selon nos informations, le gouvernement bruxellois vient de procéder (en toute discrétion) à une série de nominations importantes alors qu’il est en affaires courantes. C’est ainsi que le mandat de Julie Fiszman (étiquetée PS) vient d’être prolongé pour un nouveau bail de 5 ans à...
lpost.be
January 10, 2026 at 12:49 AM
SLRB et SPRB : nominations au parfum politique par le gouvernement bruxellois en affaires courantes
翡翠ちゃんは「ふーん」だけど某キャラはマジで「誰？？？」って感じ
CPは恋愛としては固定派だけど、種界隈で他のキャラと何らかの絆があれば恋愛未満や友情やブロマンス程度な大丈夫。×ではなく+ならOK派
だけど件の人はsprbだしな？種じゃないしな？という。クロスオーバー物でオリキャラとCPは私は無理だわー
CPは恋愛としては固定派だけど、種界隈で他のキャラと何らかの絆があれば恋愛未満や友情やブロマンス程度な大丈夫。×ではなく+ならOK派
だけど件の人はsprbだしな？種じゃないしな？という。クロスオーバー物でオリキャラとCPは私は無理だわー
December 13, 2024 at 2:31 PM
翡翠ちゃんは「ふーん」だけど某キャラはマジで「誰？？？」って感じ
CPは恋愛としては固定派だけど、種界隈で他のキャラと何らかの絆があれば恋愛未満や友情やブロマンス程度な大丈夫。×ではなく+ならOK派
だけど件の人はsprbだしな？種じゃないしな？という。クロスオーバー物でオリキャラとCPは私は無理だわー
CPは恋愛としては固定派だけど、種界隈で他のキャラと何らかの絆があれば恋愛未満や友情やブロマンス程度な大丈夫。×ではなく+ならOK派
だけど件の人はsprbだしな？種じゃないしな？という。クロスオーバー物でオリキャラとCPは私は無理だわー
link 📈🤖
The Root Finding Problem Revisited: Beyond the Robbins-Monro procedure (Yu, Banerjee, Ritov) We introduce Sequential Probability Ratio Bisection (SPRB), a novel stochastic approximation algorithm that adapts to the local behavior of the (regression) function of interest around its root. W
The Root Finding Problem Revisited: Beyond the Robbins-Monro procedure (Yu, Banerjee, Ritov) We introduce Sequential Probability Ratio Bisection (SPRB), a novel stochastic approximation algorithm that adapts to the local behavior of the (regression) function of interest around its root. W
August 26, 2025 at 5:02 PM
link 📈🤖
The Root Finding Problem Revisited: Beyond the Robbins-Monro procedure (Yu, Banerjee, Ritov) We introduce Sequential Probability Ratio Bisection (SPRB), a novel stochastic approximation algorithm that adapts to the local behavior of the (regression) function of interest around its root. W
The Root Finding Problem Revisited: Beyond the Robbins-Monro procedure (Yu, Banerjee, Ritov) We introduce Sequential Probability Ratio Bisection (SPRB), a novel stochastic approximation algorithm that adapts to the local behavior of the (regression) function of interest around its root. W
